Published in Int J Dev Neurosci on December 21, 1999
Scatter factor/hepatocyte growth factor in brain tumor growth and angiogenesis. Neuro Oncol (2005) 2.24
Blood-brain barrier breakdown in septic encephalopathy and brain tumours. J Anat (2002) 1.44
Corticosteroids in brain cancer patients: benefits and pitfalls. Expert Rev Clin Pharmacol (2011) 1.26
Neural stem cell migration toward gliomas in vitro. Neuro Oncol (2005) 1.10
Brain tumors and epilepsy: pathophysiology of peritumoral changes. Neurosurg Rev (2009) 1.05
Cyr61 mediates hepatocyte growth factor-dependent tumor cell growth, migration, and Akt activation. Cancer Res (2010) 0.96
13-cis-retinoic acid in the treatment of recurrent glioblastoma multiforme. Neuro Oncol (2004) 0.92
Role of receptor tyrosine kinases and their ligands in glioblastoma. Cells (2014) 0.91
Upregulation of vascular endothelial growth factor by hydrogen peroxide in human colon cancer. World J Gastroenterol (2002) 0.90
A new anti-c-Met antibody selected by a mechanism-based dual-screening method: therapeutic potential in cancer. Mol Cells (2012) 0.88
Blood brain barrier: a challenge for effectual therapy of brain tumors. Biomed Res Int (2015) 0.82
Immunotherapy of brain cancers: the past, the present, and future directions. Clin Dev Immunol (2011) 0.81
Tumor-derived hepatocyte growth factor is associated with poor prognosis of patients with glioma and influences the chemosensitivity of glioma cell line to cisplatin in vitro. World J Surg Oncol (2012) 0.79
An update in the use of antibodies to treat glioblastoma multiforme. Autoimmune Dis (2013) 0.78
Expression of hepatocyte growth factor and its receptor c-Met in human pituitary adenomas. Neuro Oncol (2010) 0.77
Guanine nucleotide exchange factor Dock7 mediates HGF-induced glioblastoma cell invasion via Rac activation. Br J Cancer (2014) 0.76
C-MET overexpression and amplification in gliomas. Int J Clin Exp Pathol (2015) 0.76
Quantitative Perfusion and Permeability Biomarkers in Brain Cancer from Tomographic CT and MR Images. Biomark Cancer (2016) 0.75
Cost of migration: invasion of malignant gliomas and implications for treatment. J Clin Oncol (2003) 5.28
Anti-VEGF antibody treatment of glioblastoma prolongs survival but results in increased vascular cooption. Neoplasia (2001) 4.22
Structure and composition of the adenovirus type 2 core. J Virol (1975) 3.21
Inhibition of glioma angiogenesis and growth in vivo by systemic treatment with a monoclonal antibody against vascular endothelial growth factor receptor-2. Cancer Res (2001) 3.21
Relationship of weight gain during pregnancy to birth weight and infant growth and development in the first year of life. Obstet Gynecol (1968) 3.02
Scatter factor induces blood vessel formation in vivo. Proc Natl Acad Sci U S A (1993) 2.86
Glioblastoma-derived stem cell-enriched cultures form distinct subgroups according to molecular and phenotypic criteria. Oncogene (2007) 2.82
Patterns of integration of viral DNA sequences in the genomes of adenovirus type 12-transformed hamster cells. Cell (1978) 2.82
Glioma invasion in the central nervous system. Neurosurgery (1996) 2.60
BRCA1 inhibition of estrogen receptor signaling in transfected cells. Science (1999) 2.54
Abnormal autolytic enzyme in a pneumococus with altered teichoic acid composition. Proc Natl Acad Sci U S A (1971) 2.51
Cell surface heparan sulfate mediates some adhesive responses to glycosaminoglycan-binding matrices, including fibronectin. J Cell Biol (1983) 2.35
Transcription of the genome of adenovirus type 12. III. Maps of stable RNA from productively infected human cells and abortively infected and transformed hamster cells. J Virol (1976) 2.12
Role of direct interaction in BRCA1 inhibition of estrogen receptor activity. Oncogene (2001) 1.82
On the physiological functions of teichoic acids. J Supramol Struct (1975) 1.76
Incomplete particles of adenovirus. II. Kinetics of formation and polypeptide composition of adenovirus type 2. Virology (1974) 1.74
Invasion as limitation to anti-angiogenic glioma therapy. Acta Neurochir Suppl (2003) 1.59
Scatter factor/hepatocyte growth factor protects against cytotoxic death in human glioblastoma via phosphatidylinositol 3-kinase- and AKT-dependent pathways. Cancer Res (2000) 1.56
Complete sequence and transcript regulation of a cell adhesion protein from aggregating Dictyostelium cells. EMBO J (1986) 1.55
Effects of short-term simultaneous infusion of dobutamine and terlipressin in patients with septic shock: the DOBUPRESS study. Br J Anaesth (2008) 1.55
Levels of vascular endothelial growth factor, hepatocyte growth factor/scatter factor and basic fibroblast growth factor in human gliomas and their relation to angiogenesis. Int J Cancer (1999) 1.52
Expression of interleukin-1beta in human breast carcinoma. Cancer (1997) 1.52
Expression of scatter factor and c-met receptor in benign and malignant breast tissue. Cancer (1997) 1.50
Alcohol stimulates estrogen receptor signaling in human breast cancer cell lines. Cancer Res (2000) 1.46
G protein beta subunit-null mutants are impaired in phagocytosis and chemotaxis due to inappropriate regulation of the actin cytoskeleton. J Cell Biol (1998) 1.46
Reversion of human glioblastoma malignancy by U1 small nuclear RNA/ribozyme targeting of scatter factor/hepatocyte growth factor and c-met expression. J Natl Cancer Inst (1999) 1.44
Cellular senescence in a cloned strain of bovine fetal aortic endothelial cells. Science (1980) 1.41
Glycosaminoglycans that bind cold-insoluble globulin in cell-substratum adhesion sites of murine fibroblasts. Proc Natl Acad Sci U S A (1980) 1.36
Close and focal contact adhesions of fibroblasts to a fibronectin-containing matrix. Fed Proc (1985) 1.36
Three-dimensional structure of Fab R19.9, a monoclonal murine antibody specific for the p-azobenzenearsonate group. Proc Natl Acad Sci U S A (1989) 1.35
Neurovirulent simian immunodeficiency virus replicates productively in endothelial cells of the central nervous system in vivo and in vitro. J Virol (1994) 1.33
Regulation of glioblastoma stem cells by retinoic acid: role for Notch pathway inhibition. Oncogene (2011) 1.33
The cytokine hepatocyte growth factor/scatter factor inhibits apoptosis and enhances DNA repair by a common mechanism involving signaling through phosphatidyl inositol 3' kinase. Oncogene (2000) 1.31
Dictyostelium cells' cytoplasm as an active viscoplastic body. Eur Biophys J (2001) 1.30
BRCA1 and BRCA2 as molecular targets for phytochemicals indole-3-carbinol and genistein in breast and prostate cancer cells. Br J Cancer (2006) 1.27
Early Dictyostelium development: control mechanisms bypassed by sequential mutagenesis. Cold Spring Harb Symp Quant Biol (1985) 1.27
Scatter factor promotes motility of human glioma and neuromicrovascular endothelial cells. Int J Cancer (1998) 1.26
Activation of estrogen signaling pathways collaborates with loss of Brca1 to promote development of ERalpha-negative and ERalpha-positive mammary preneoplasia and cancer. Oncogene (2007) 1.24
Differences in hyaluronate binding to plasma and cell surface fibronectins. Requirement for aggregation. J Biol Chem (1982) 1.23
Microtubule-mediated centrosome motility and the positioning of cleavage furrows in multinucleate myosin II-null cells. J Cell Sci (1998) 1.22
Migration of human glioma cells on myelin. Neurosurgery (1996) 1.20
BRCA1 as a potential human prostate tumor suppressor: modulation of proliferation, damage responses and expression of cell regulatory proteins. Oncogene (1998) 1.18
Induction of vascular endothelial growth factor in human astrocytes by lead. Involvement of a protein kinase C/activator protein-1 complex-dependent and hypoxia-inducible factor 1-independent signaling pathway. J Biol Chem (2000) 1.15
Probing an adhesion mutant of Dictyostelium discoideum with cDNA clones and monoclonal antibodies indicates a specific defect in the contact site A glycoprotein. EMBO J (1985) 1.15
Response of avian embryonic brain to spatially segmented x-ray microbeams. Cell Mol Biol (Noisy-le-grand) (2001) 1.15
Scatter factor expression and regulation in human glial tumors. Int J Cancer (1996) 1.15
Coordinated incorporation of nascent peptidoglycan and teichoic acid into pneumococcal cell walls and conservation of peptidoglycan during growth. J Biol Chem (1975) 1.15
Monoclonal antibodies against contact sites A of Dictyostelium discoideum: detection of modifications of the glycoprotein in tunicamycin-treated cells. EMBO J (1982) 1.14
Inhibition of tumor growth and metastasis of human breast cancer cells transfected with tissue inhibitor of metalloproteinase 4. Oncogene (1997) 1.14
The multisubstrate adapter Gab1 regulates hepatocyte growth factor (scatter factor)-c-Met signaling for cell survival and DNA repair. Mol Cell Biol (2001) 1.13
The contractile vacuole network of Dictyostelium as a distinct organelle: its dynamics visualized by a GFP marker protein. J Cell Sci (1999) 1.13
Modulation of HGF-induced tubulogenesis and branching by multiple phosphorylation mechanisms. Dev Biol (1993) 1.13
Allelic losses at 1p, 9q, 10q, 14q, and 22q in the progression of aggressive meningiomas and undifferentiated meningeal sarcomas. Cancer Genet Cytogenet (1999) 1.12
EphB2 receptor controls proliferation/migration dichotomy of glioblastoma by interacting with focal adhesion kinase. Oncogene (2012) 1.12
Constitutive activation of JAK-STAT3 signaling by BRCA1 in human prostate cancer cells. FEBS Lett (2001) 1.12
Differential expression of novH and CTGF in human glioma cell lines. Clin Mol Pathol (1996) 1.11
Relationship of VH and VL genes encoding three idiotypic families of anti-p-azobenzenearsonate antibodies. Proc Natl Acad Sci U S A (1986) 1.11
Weight gain during pregnancy and prepregnancy weight. Association with birth weight of term gestation. Obstet Gynecol (1969) 1.10
Scatter factor protects epithelial and carcinoma cells against apoptosis induced by DNA-damaging agents. Oncogene (1998) 1.10
Signal transduction in c-met mediated motogenesis. EXS (1993) 1.10
Scatter factor stimulates tumor growth and tumor angiogenesis in human breast cancers in the mammary fat pads of nude mice. Lab Invest (1997) 1.10
Inhibitory effects of Indole-3-carbinol on invasion and migration in human breast cancer cells. Breast Cancer Res Treat (2000) 1.09
Contact formation by fibroblasts adhering to heparan sulfate-binding substrata (fibronectin or platelet factor 4). Exp Cell Res (1983) 1.08
Gross total but not incomplete resection of glioblastoma prolongs survival in the era of radiochemotherapy. Ann Oncol (2013) 1.06
Vascular endothelial growth factor, hepatocyte growth factor/scatter factor, basic fibroblast growth factor, and placenta growth factor in human meningiomas and their relation to angiogenesis and malignancy. Neurosurgery (2000) 1.06
HGF/SF in angiogenesis. Ciba Found Symp (1997) 1.06
Proliferative characteristics of clonal endothelial cell strains. J Cell Physiol (1981) 1.05
Treatment of malignant glioma: a problem beyond the margins of resection. J Cancer Res Clin Oncol (2001) 1.04
Regulation of BRCA1 and BRCA2 expression in human breast cancer cells by DNA-damaging agents. Oncogene (1998) 1.04
Signaling pathways in the induction of c-met receptor expression by its ligand scatter factor/hepatocyte growth factor in human glioblastoma. J Neurochem (2001) 1.02
Neuroblastoma: the Joint Center for Radiation Therapy/Dana-Farber Cancer Institute/Children's Hospital experience. J Clin Oncol (1984) 1.01
Indole-3-carbinol is a negative regulator of estrogen receptor-alpha signaling in human tumor cells. J Nutr (2000) 1.00
Effect of scatter factor and hepatocyte growth factor on motility and morphology of MDCK cells. In Vitro Cell Dev Biol (1992) 1.00
Role of scatter factor in the pathogenesis of AIDS-related Kaposi sarcoma. Proc Natl Acad Sci U S A (1994) 1.00
Complete cDNA sequence of a Dictyostelium ubiquitin with a carboxy-terminal tail and identification of the protein using an anti-peptide antibody. FEBS Lett (1988) 0.99
A hammerhead ribozyme suppresses expression of hepatocyte growth factor/scatter factor receptor c-MET and reduces migration and invasiveness of breast cancer cells. Clin Cancer Res (2001) 0.99
Suppression of breast cancer invasion and migration by indole-3-carbinol: associated with up-regulation of BRCA1 and E-cadherin/catenin complexes. J Mol Med (Berl) (2000) 0.99
Disarrangement of fiber tracts and decline of neuronal density correlate in glioma patients--a combined diffusion tensor imaging and 1H-MR spectroscopy study. AJNR Am J Neuroradiol (2006) 0.98
Disruption of BRCA1 LXCXE motif alters BRCA1 functional activity and regulation of RB family but not RB protein binding. Oncogene (2001) 0.98
Local convection enhanced delivery of IL4-Pseudomonas exotoxin (NBI-3001) for treatment of patients with recurrent malignant glioma. Acta Neurochir Suppl (2003) 0.98
X-ray microbeams: Tumor therapy and central nervous system research. Nucl Instrum Methods Phys Res A (2005) 0.98
Glioma cell adhesion and migration on human brain sections. Anticancer Res (1998) 0.98
Squalamine inhibits angiogenesis and solid tumor growth in vivo and perturbs embryonic vasculature. Cancer Res (1998) 0.98
Ultrasound-guided surgery of deep seated brain lesions. Eur J Ultrasound (2000) 0.97
Expression and localization of scatter factor/hepatocyte growth factor in human astrocytomas. Neuro Oncol (2001) 0.97
Growth factors in gliomas revisited. Acta Neurochir (Wien) (2000) 0.96
Heparan sulphate proteoglycan as mediator of some adhesive responses and cytoskeletal reorganization of cells on fibronectin matrices: independent versus cooperative functions. Ciba Found Symp (1986) 0.96
A chimeric mouse-human antibody that retains specificity for HIV gp120 and mediates the lysis of HIV-infected cells. J Immunol (1989) 0.96
Endothelial differentiation in intracerebral and subcutaneous experimental gliomas. Brain Res (1994) 0.96
The glucose transporter and blood-brain barrier of human brain tumors. Ann Neurol (1990) 0.95
Efficacy and safety of 10% HES 130/0.4 versus 10% HES 200/0.5 for plasma volume expansion in cardiac surgery patients. Minerva Med (2012) 0.95
A developmentally regulated gene product from Dictyostelium discoideum shows high homology to human alpha-L-fucosidase. FEBS Lett (1989) 0.95
Multimodal fetal transesophageal echocardiography for fetal cardiac intervention in sheep. Circulation (2001) 0.95
Expression of scatter factor in human bladder carcinoma. J Natl Cancer Inst (1995) 0.94